Skip to main navigation

ABOUT US

Management
Board of Directors

CLINICAL PROGRAMS

Our Focus
IDO Pathway & Indoximod
Posters & Publications

COLLABORATION

Industry
Advocacy

CAREERS

Culture
Benefits
Jobs

INVESTORS & MEDIA

Investor Relations

Investor Relations
Press Releases
Events & Presentations
Posters & Publications
Corporate Governance
Financial Information
- SEC Filings
- Quarterly Results
Analyst Coverage
Investor FAQs

Contact us

Investors & Media

Home > Investor Relations > Quarterly Results

Quarterly Results

Show all

2019

First Quarter

NewLink Genetics Reports First Quarter 2019 Financial Results and Provides Clinical Activities Update
First Quarter 2019 Earnings Conference Call
Form 10-Q

2018

Fourth Quarter

NewLink Genetics Reports Fourth Quarter, Year-End 2018 Financial Results and Provides Update for Clinical Programs
Fourth Quarter 2018 Earnings Conference Call
Form 10-K

Third Quarter

NewLink Genetics Reports Third Quarter 2018 Financial Results and Announces Abstracts to Be Presented at Upcoming Medical Meetings
Third Quarter 2018 Earnings Conference Call
Form 10-Q

Second Quarter

NewLink Genetics Announces Clinical Plan, Reports Second Quarter 2018 Financial Results and Revises Cash Guidance
Second Quarter 2018 Earnings Conference Call
Form 10-Q

First Quarter

NewLink Genetics Reports First Quarter 2018 Financial Results
First Quarter 2018 Earnings Conference Call
Form 10-Q

2017

Fourth Quarter

NewLink Genetics Reports Fourth Quarter, Year-End 2017 Financial Results and Provides Update for Indoximod Programs
Fourth Quarter 2017 Earnings Conference Call
Form 10-K

Third Quarter

NewLink Genetics Reports Third Quarter 2017 Financial Results and Updates Indoximod Program
Form 10-Q

Second Quarter

NewLink Genetics Reports Second Quarter 2017 Financial Results and Updates Indoximod Program
Form 10-Q

First Quarter

NewLink Genetics Reports First Quarter 2017 Financial Results and Updates Clinical Trial Guidance
Form 10-Q

2016

Fourth Quarter

NewLink Genetics Provides Operational &amp; Clinical Update, Reports Fourth Quarter, Year-End 2016 Financial Results
Form 10-K

Third Quarter

NewLink Genetics Corporation Provides Operational Update and Reports Third Quarter 2016 Financial Results
Form 10-Q

Second Quarter

NewLink Genetics Reports Second Quarter 2016 Financial Results
Form 10-Q

First Quarter

NewLink Genetics Reports First Quarter 2016 Financial Results
Form 10-Q

2015

Fourth Quarter

NewLink Genetics Provides Operational Update and Reports Fourth Quarter, Year End 2015 Financial Results
Form 10-K

Third Quarter

NewLink Genetics Corporation Provides Operational Update and Reports Third Quarter 2015 Financial Results
Form 10-Q

Second Quarter

NewLink Genetics Corporation Provides Operational Update and Reports Second Quarter 2015 Financial Results
Form 10-Q

First Quarter

NewLink Genetics Corporation Provides Operational Update and Reports First Quarter 2015 Financial Results
Form 10-Q

2014

Fourth Quarter

NewLink Genetics Corporation Provides Operational Update and Reports Fourth Quarter and Year End 2014 Financial Results
Form 10-K

Third Quarter

NewLink Genetics Corporation Reports Third Quarter 2014 Financial Results
Form 10-Q

Second Quarter

NewLink Genetics Corporation Reports Second Quarter 2014 Financial Results
Form 10-Q

First Quarter

NewLink Genetics Corporation Reports First Quarter 2014 Financial Results
Form 10-Q

2013

Fourth Quarter

NewLink Genetics Corporation Reports Fourth Quarter and Year End 2013 Financial Results
Form 10-K

Third Quarter

NewLink Genetics Corporation Reports Third Quarter 2013 Financial Results
Form 10-Q

Second Quarter

NewLink Genetics Corporation Reports Second Quarter 2013 Financial Results
Form 10-Q

First Quarter

NewLink Genetics Corporation Reports First Quarter 2013 Financial Results
Form 10-Q

2012

Fourth Quarter

NewLink Genetics Reports Fourth Quarter and Full-Year 2012 Financial Results

Third Quarter

NewLink Genetics Corporation Reports Third Quarter 2012 Financial Results
Form 10-Q

Second Quarter

NewLink Genetics Corporation Reports Second Quarter 2012 Financial Results
Form 10-Q

First Quarter

NewLink Genetics Corporation Reports First Quarter 2012 Financial Results
Form 10-Q

2011

Fourth Quarter

NewLink Genetics Corporation Reports Fourth Quarter and Full-Year 2011 Financial Results
Form 10-K

Shareholder Tools

Email Alerts Subscription
Download Library
Print
Share

Facebook
Google
LinkedIn
Twitter
RSS

About Us
Management
Board of Directors

Clinical Programs
Our Focus
IDO Pathway & Indoximod
Posters & Publications

Collaboration
Industry
Advocacy

Careers
Culture
Benefits
Jobs

Investors and Media

Investor Relations

Investor Relations
Press Releases
Events & Presentations
Posters & Publications
Corporate Governance
Financial Information
- SEC Filings
- Quarterly Results
Analyst Coverage
Investor FAQs

©2019 NewLink Genetics Corporation. All rights reserved.

Terms & Conditions | Privacy Policy | Contact Us